期刊文献+

C-Met蛋白在结直肠癌中的表达及其与肿瘤血管生成的关系 被引量:1

Correlation between c-Met expression and tumor angiogenesis in colorectal cancer
下载PDF
导出
摘要 目的:检测结直肠癌组织中c-Met蛋白表达情况并计数其微血管密度(microvessel density,MVD)值,探讨两者之间的相互关系,评价其与结直肠癌临床病理特征的关系.方法:对我院病理科2009-2010年经手术切除经病理证实的结直肠癌、癌旁组织及正常组织标本各40例,采用Western blot和SP法分别检测3种组织中c-Met蛋白表达和CD34标记的MVD.结果:c-Met蛋白在结直肠癌组织中阳性表达率明显高于结直肠癌旁组织与正常黏膜组织(χ2=29.39,P≤0.01).结直肠癌组织中MVD明显高于结直肠癌旁组织和正常黏膜组织(H=90.468,P≤0.01).结直肠癌组织c-Met蛋白表达和MVD与浸润深度(P<0.05)、Dukes分期(P<0.05)、淋巴结转移及远处转移(P<0.05)密切相关,c-Met阳性表达的结直肠癌组织中MVD显著高于c-Met阴性者(t=3.126,P<0.01).结论:结直肠癌患者的c-Met及MVD值高于癌旁组织及正常黏膜组织,且随着结直肠癌的不断进展,两者在结直肠癌的侵袭和转移中发挥着重要作用,联合检测c-Met的表达及MVD可能有助于结直肠癌临床评价和预后判断. AIM: To investigate the correlation between ex- pression of c-Met protein and microvessel den- sity (MVD) in colorectal carcinoma and to assess their clinical significance. METHODS: Immunohistochemical SP method was used to detect the expression of c-Met pro- tein and CD34 (for assessment of MVD) in 40 cases of colorectal carcinoma, 40 cases of tumor- adjacent neoplastic tissue and 40 cases of normal colorectal tissue.RESULTS: The positive rate of c-Met expres- sion in colorectal carcinoma was significantly higher than that in adenoma and normal tissue (3(2 = 29.39, P 〈 0.01). The MVD in colorectal car- cinoma was also significantly higher than that in adenoma and normal tissue (H = 90.468, P 〈 0.01). C-Met expression and MVD had no correlation with tumor site and histological stage, but were closely related to Dukes stage, depth of invasion, lymph node metastasis and distant metastasis (all P 〈 0.05). The MVD in c-Met-positive rectal can- cer was higher than that in c-Met-negative rectal cancer (t ^- 3.126, P 〈 0.01). CONCLUSION: C-Met possibly plays an im- portant role in the invasion and metastasis of colorectal carcinoma. Combined detection of c-Met expression and MVD may be helpful for judging prognosis in colorectal carcinoma.
出处 《世界华人消化杂志》 CAS 北大核心 2013年第8期734-738,共5页 World Chinese Journal of Digestology
关键词 结直肠癌 C-MET 微血管密度 免疫组织化学 WESTERN BLOT Colonal cancer C-Met Microvessel density Immunohistochemistry Western blot
  • 相关文献

参考文献4

二级参考文献94

  • 1Morson B C. Evolution of cancer of the colon and rectum[J]. Cancer, 1974,34(3):845-849.
  • 2Fujita S, Sugano K. Expression of c-met proto-oncogene in primary colorectal cancer and liver metastases[J]. Jpn J Clin oncol, 1997,27(6):378-383.
  • 3Kammula U S, Kuntz E J, Francone T D, et al. Molecular co-expression of the c-met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome[J]. Cancer Lett,2007, 248(2) :219-228.
  • 4Takeuchi H, Bilchik A, Saha S, et al. c-met expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases[J]. Clin cancer Res, 2003,9(4):1480-1488.
  • 5Canoglu A, Gogus C, Beduk Y, et al. Microvessel density as a prognostic marker in bladder carcinoma:correlation with tumor grade,stage and prognosis[J]. Int Urol Nephrol,2004,36(3):401 -405.
  • 6Tsutsui S, Kume M, Era S. Prognostic value of microvessel density in invasive ductal carcinoma of the breast [ J ]. Breast Cancer, 2003, 10 (4) :312 - 319.
  • 7Kaku T, Kamura T, Kinukawa N, et al. Angiogenesis in endometrial carcinoma[ J ]. Cancer, 1997,80(4) : 741 - 747.
  • 8Dalai S, Berry AM, Cullinane CJ, et al. Vascular endothelial growth factor: a therapeutic target for tumors of the Ewing' s sarcoma family [J]. Clin Cancer Res,2005,11 (6) :2364 - 2378.
  • 9Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease[J]. Nat Med, 1995,1(1):27-31.
  • 10Turner HE, Harris AL, Melmed S, et al. Angiogenesis in endocrine tumors[ J]. Endocr Rev,2003,24(5) :600 - 632.

共引文献41

同被引文献29

  • 1Dai R, Li J, Fu J, Chen Y, Yu L, Zhao X, Qian Y, Zhang H, Chert H, Ren Y, Su B, Luo T, Zhu J, Wang H. Disturbance of Ca2+ homeostasis converts pro- Met into non-canonical tyrosine kinase p190MetNC in response to endoplasmic reticulum stress in MHCC97 cells. J Biol Chem 2012; 287:14586-14597 [PMID: 22418436 DOI: 10.1074/ibc.M111.333435].
  • 2Ferracini R, Longati P, Naldini L, Vigna E, Como- glio PM. Identification of the major autophosphory- lation site of the Met/hepatocyte growth factor receptor tyrosine kinase. J Biol Chem 1991; 266: 19558-19564 [PMID: 1655790].
  • 3Crider SE, Holbrook RJ, Franz KJ. Coordination of platinum therapeutic agents to met-rich motifs of human copper transport protein1. Metallomics 2010; 2:74-83 [PMID: 21072377 DOI: 10.1039/b916899k].
  • 4Dai RY, Chen Y, Fu J, Dong LW, Ren YB, Yang GZ, Qian YW, Cao J, Tang SH, Yang SL, Wang HY. p28GANK inhibits endoplasmic reticulum stress-induced cell death via enhancement of the endoplasmic reticulum adaptive capacity. Cell Res 2009; 19:1243-1257 [PMID: 19736567 DOI: 10.1038/ cr.2009.104].
  • 5Pant S, Saleh M, Bendell J, Infante JR, Jones S, Kurkjian CD, Moore KM, Kazakin J, Abbadessa G, Wang Y, Chen Y, Schwartz B, Camacho LH. A Phase I Dose Escalation Study of Oral c-MET In- hibitor Tivantinib (ARQ 197) in Combination with Gemcitabine in Patients with Solid Tumors. Ann Oncol 2014 Apr 15. [Epub ahead of print] [PMID: 24737778].
  • 6Li H, Hu H, Wang R, Pan Y, Wang L, Li Y, Zhang Y, Ye T, Zhang Y, Li B, Shen L, Sun Y, Chen H. Pri- mary concomitant EGFR T790M mutation predicted worse prognosis in non-small cell lung cancer patients. Onco Targets Ther 2014; 7:513-524 [PMID: 24729716 DOI: 10.2147/OTT.$60122].
  • 7Leung KK, Hause RJ Jr, Barkinge JL, Ciaccio MF, Chuu CP, Jones RB. Enhanced prediction of SH2 domain binding potentials using a fluorescence po- larization-derived c-Met, c-Kit, ErbB, and androgen receptor interactome. Mol Cell Proteomics 2014 Apr 12. [Epub ahead of print] [PMID: 24728074].
  • 8Zhang W, Ai J, Shi D, Peng X, Ji Y, Liu J, Geng M, Li Y. Discovery of novel c-Met inhibitors bearing a 3-carboxyl piperidin-2-one scaffold. Molecules 2014; 19:2655-2673 [PMID: 24566328 DOI: 10.3390/mol- eculeslg022655].
  • 9You H, Ding W, Dang H, Jiang Y, Rountree CB. c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma. Hepatology 2011; 54:879-889 [PMID: 21618573 DOI: lO.1002/hep.24450].
  • 10Pandit VU, Arbuj SS, Mulik UP, Kale BB. Novelfunctionality of organic 6,13-Pentacenequinone as a photocatalyst for hydrogen production under solar light. Environ Sci Techno12014; 48:4178-4183 [PMID: 24597841 DOE 10.1021/es405150p].

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部